Cargando…

Latex immunotherapy: evidence of effectiveness

INTRODUCTION: The only etiological and decisive therapy, able to influence the natural history of latex allergy is the specific desensitization. AIM: To verify the clinical efficacy and immunological changes determined by latex sublingual immunotherapy in allergic patients who underwent this treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Nucera, Eleonora, Mezzacappa, Simona, Buonomo, Alessandro, Centrone, Michele, Rizzi, Angela, Manicone, Paolo Francesco, Patriarca, Giampiero, Aruanno, Arianna, Schiavino, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949543/
https://www.ncbi.nlm.nih.gov/pubmed/29760613
http://dx.doi.org/10.5114/ada.2018.75235
_version_ 1783322735543320576
author Nucera, Eleonora
Mezzacappa, Simona
Buonomo, Alessandro
Centrone, Michele
Rizzi, Angela
Manicone, Paolo Francesco
Patriarca, Giampiero
Aruanno, Arianna
Schiavino, Domenico
author_facet Nucera, Eleonora
Mezzacappa, Simona
Buonomo, Alessandro
Centrone, Michele
Rizzi, Angela
Manicone, Paolo Francesco
Patriarca, Giampiero
Aruanno, Arianna
Schiavino, Domenico
author_sort Nucera, Eleonora
collection PubMed
description INTRODUCTION: The only etiological and decisive therapy, able to influence the natural history of latex allergy is the specific desensitization. AIM: To verify the clinical efficacy and immunological changes determined by latex sublingual immunotherapy in allergic patients who underwent this treatment for at least 3 years. MATERIAL AND METHODS: We enrolled 76 patients (16 males and 60 females, mean age 34 years old) with evidence of a natural rubber latex allergy. To assess the effectiveness of the immunotherapy we performed a latex skin prick test, specific IgE and IgG4 and challenge tests before and after at least 3 years of desensitization. RESULTS: We observed a reduction in the mean diameter of the wheal area at the skin prick test and a decrease in latex specific IgE while no significant changes of latex IgG4 values were found. Moreover a reduction of symptoms and scores at the provocation tests were remarked. CONCLUSIONS: Although the primary prevention (which still remains the gold standard treatment for patients suffering from the latex allergy) sublingual immunotherapy can be offered with efficacy in addition to symptomatic treatment to selected patients.
format Online
Article
Text
id pubmed-5949543
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-59495432018-05-14 Latex immunotherapy: evidence of effectiveness Nucera, Eleonora Mezzacappa, Simona Buonomo, Alessandro Centrone, Michele Rizzi, Angela Manicone, Paolo Francesco Patriarca, Giampiero Aruanno, Arianna Schiavino, Domenico Postepy Dermatol Alergol Original Paper INTRODUCTION: The only etiological and decisive therapy, able to influence the natural history of latex allergy is the specific desensitization. AIM: To verify the clinical efficacy and immunological changes determined by latex sublingual immunotherapy in allergic patients who underwent this treatment for at least 3 years. MATERIAL AND METHODS: We enrolled 76 patients (16 males and 60 females, mean age 34 years old) with evidence of a natural rubber latex allergy. To assess the effectiveness of the immunotherapy we performed a latex skin prick test, specific IgE and IgG4 and challenge tests before and after at least 3 years of desensitization. RESULTS: We observed a reduction in the mean diameter of the wheal area at the skin prick test and a decrease in latex specific IgE while no significant changes of latex IgG4 values were found. Moreover a reduction of symptoms and scores at the provocation tests were remarked. CONCLUSIONS: Although the primary prevention (which still remains the gold standard treatment for patients suffering from the latex allergy) sublingual immunotherapy can be offered with efficacy in addition to symptomatic treatment to selected patients. Termedia Publishing House 2018-04-24 2018-04 /pmc/articles/PMC5949543/ /pubmed/29760613 http://dx.doi.org/10.5114/ada.2018.75235 Text en Copyright: © 2018 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Nucera, Eleonora
Mezzacappa, Simona
Buonomo, Alessandro
Centrone, Michele
Rizzi, Angela
Manicone, Paolo Francesco
Patriarca, Giampiero
Aruanno, Arianna
Schiavino, Domenico
Latex immunotherapy: evidence of effectiveness
title Latex immunotherapy: evidence of effectiveness
title_full Latex immunotherapy: evidence of effectiveness
title_fullStr Latex immunotherapy: evidence of effectiveness
title_full_unstemmed Latex immunotherapy: evidence of effectiveness
title_short Latex immunotherapy: evidence of effectiveness
title_sort latex immunotherapy: evidence of effectiveness
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949543/
https://www.ncbi.nlm.nih.gov/pubmed/29760613
http://dx.doi.org/10.5114/ada.2018.75235
work_keys_str_mv AT nuceraeleonora lateximmunotherapyevidenceofeffectiveness
AT mezzacappasimona lateximmunotherapyevidenceofeffectiveness
AT buonomoalessandro lateximmunotherapyevidenceofeffectiveness
AT centronemichele lateximmunotherapyevidenceofeffectiveness
AT rizziangela lateximmunotherapyevidenceofeffectiveness
AT maniconepaolofrancesco lateximmunotherapyevidenceofeffectiveness
AT patriarcagiampiero lateximmunotherapyevidenceofeffectiveness
AT aruannoarianna lateximmunotherapyevidenceofeffectiveness
AT schiavinodomenico lateximmunotherapyevidenceofeffectiveness